Stock market week-in-review for 5 large GI companies — Dec. 11-15

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Dec. 11 to Dec. 15, 2017.

Advertisement

Note: This data was compiled using Yahoo Finance.

1. Allergan Pharmaceuticals

Opened: $168.75 on Dec. 11
Peaked: $175.20 on Dec. 14
Closed: $171.68 on Dec. 15
Percent change between Dec. 11 and Dec. 15: 1.73 percent

2. Exact Sciences Corp.

Opened: $53.58 on Dec. 11
Peaked: $53.96 on Dec. 11
Closed: $51.56 on Dec. 15
Percent change between Dec. 11 and Dec. 15: -3.77 percent

3. Johnson & Johnson

Opened: $140.90 on Dec. 11
Peaked: $143.57 on Dec. 12
Closed: $142.46 on Dec. 15
Percent change between Dec. 11 and Dec. 15: 1.1 percent

4. Synergy Pharmaceuticals

Opened: $1.93 on Dec. 11
Peaked: $2.10 on Dec. 15
Closed: $2.01 on Dec. 15
Percent change between Dec. 11 and Dec. 15: 4.14 percent

5. Valeant Pharmaceuticals

Opened: $19.80 on Dec. 11
Peaked: $22.81 on Dec. 13
Closed: $19.71 on Dec. 15
Percent change between Dec. 11 and Dec. 15: -0.45 percent

More articles on gastroenterology: 
GI leader to know: Dr. Anil Sharma of Gastroenterology Group of Rochester
82% of early-onset CRC cases misdiagnosed — 10 study insights
Takeda, TiGenix’s complex perianal fistulas treatment receives 1st ever positive EMA opinion — 3 insights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.